| 1 |
Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain [J]. Arch Neurol, 1969, 20(3): 288-299.
|
| 2 |
Kleinloog R, Regli L, Rinkel GJE, et al. Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review [J]. J Neurol Neurosurg Psychiatry, 2012, 83(5): 531-536.
|
| 3 |
Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis) [J]. Neurol Med Chir (Tokyo), 2012, 52(5): 245-266.
|
| 4 |
Kim SK, Cho BK, Phi JH, et al. Pediatric moyamoya disease: an analysis of 410 consecutive cases [J]. Ann Neurol, 2010, 68(1): 92-101.
|
| 5 |
Liu X, Zhang D, Wang S, et al. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China [J]. J Neurosurg, 2015, 122(2): 392-399.
|
| 6 |
Karasawa J, Touho H, Ohnishi H, et al. Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease [J]. J Neurosurg, 1992, 77(1): 84-89.
|
| 7 |
Goda M, Isono M, Ishii K, et al. Long-term effects of indirect bypass surgery on collateral vessel formation in pediatric moyamoya disease [J]. J Neurosurg, 2004, 100(2 Suppl Pediatrics): 156-162.
|
| 8 |
徐斌, 顾宇翔. 烟雾病和烟雾综合征诊断与治疗中国专家共识(2017) [J]. 中华神经外科杂志, 2017, 33(6): 541-547.
|
| 9 |
Currie SM, Raghavan AM, Batty RM, et al. Childhood moyamoya disease and moyamoya syndrome: a pictorial review [J]. Pediatr Neurol, 2011, 44(6): 401-413.
|
| 10 |
Hayashi K, Horie N, Suyama K, et al. An epidemiological survey of moyamoya disease, unilateral moyamoya disease and quasi-moyamoya disease in Japan [J]. Clin Neurol Neurosurg, 2013, 115(7): 930-933.
|
| 11 |
Hoshino H, Izawa Y, Suzuki N. Epidemiological features of moyamoya disease in Japan [J]. Neurol Med Chir (Tokyo), 2012, 52(5): 295-298.
|
| 12 |
Kim T, Lee H, Bang JS, et al. Epidemiology of moyamoya disease in Korea: based on national health insurance service data [J]. J Korean Neurosurg Soc, 2015, 57(6): 390-395.
|
| 13 |
Uchino K, Johnston SC, Becker KJ, et al. Moyamoya disease in Washington State and California [J]. Neurology, 2005, 65(6): 956-958.
|
| 14 |
Chen P, Yang S, Chien K, et al. Epidemiology of moyamoya disease in Taiwan: a nationwide population-based study [J]. Stroke, 2014, 45(5): 1258-1263.
|
| 15 |
Miao W, Zhao PL, Zhang YS, et al. Epidemiological and clinical features of moyamoya disease in Nanjing, China [J]. Clin Neurol Neurosurg, 2010, 112(3): 199-203.
|
| 16 |
唐斌, 徐建平, 王志刚, 等. 江西地区烟雾病的临床特征及外科治疗分析 [J]. 中华神经医学杂志, 2017, 16(7): 719-724.
|
| 17 |
Duan L, Bao X, Yang W, et al. Moyamoya disease in China: its clinical features and outcomes [J]. Stroke, 2012, 43(1): 56-60.
|
| 18 |
孙玮良, 赵黎明, 梁浩, 等. 烟雾病的临床特征及外科治疗的流行病学分析 [J]. 中国实用神经疾病杂志, 2020, 23(6): 485-490.
|
| 19 |
Ikezaki K, Han DH, Kawano T, et al. A clinical comparison of definite moyamoya disease between South Korea and Japan [J]. Stroke, 1997, 28(12): 2513-2517.
|
| 20 |
Bao XY, Wang QN, Zhang Y, et al. Epidemiology of moyamoya disease in China: single-center, population-based study [J]. World Neurosurgery, 2019, 122: e917-e923.
|
| 21 |
Wang J, Licht DJ, Jahng GH, et al. Pediatric perfusion imaging using pulsed arterial spin labeling [J]. J Magn Reson Imaging, 2003, 18(4): 404-413.
|
| 22 |
Quon JL, Kim LH, Lober RM, et al. Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome [J]. J Neurosurg Pediatr, 2019, 23(4): 486-492.
|
| 23 |
Takahashi JC, Miyamoto S. Moyamoya disease: recent progress and outlook [J]. Neurol Med Chir (Tokyo), 2010, 50(9): 824-832.
|
| 24 |
Kawaguchi S, Sakaki T, Morimoto T, et al. Characteristics of intracranial aneurysms associated with moyamoya disease. A review of 111 cases [J]. Acta Neurochir (Wien), 1996, 138(11): 1287-1294.
|
| 25 |
Jang DK, Lee KS, Rha HK, et al. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults [J]. J Neurosurg, 2017, 127(3): 492-502.
|
| 26 |
Kim T, Oh CW, Bang JS, et al. Moyamoya disease: treatment and outcomes [J]. J Stroke, 2016, 18(1): 21-30.
|
| 27 |
Appireddy R, Ranjan M, Durafourt BA, et al. Surgery for Moyamoya Disease in Children [J]. J Child Neurol, 2019, 34(9): 517-529.
|
| 28 |
Gadgil N, Lam S, Pyarali M, et al. Indirect revascularization with the dural inversion technique for pediatric moyamoya disease: 20-year experience [J]. J Neurosurg Pediatr, 2018, 22(5): 541-549.
|
| 29 |
Ha EJ, Kim KH, Wang KC, et al. Long-term outcomes of indirect bypass for 629 children with moyamoya disease: longitudinal and cross-sectional analysis [J]. Stroke, 2019, 50(11): 3177-3183.
|
| 30 |
Malek AM, Connors S, Robertson RL, et al. Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders [J]. Pediatr Neurosurg, 1997, 27(4): 182-189.
|
| 31 |
Jin SC, Oh CW, Kwon OK, et al. Epilepsy after bypass surgery in adult moyamoya disease [J]. Neurosurgery, 2011, 68(5): 1227-1232, 1232.
|
| 32 |
杨恒, 苏佳斌, 倪伟, 等. 烟雾病脑血流重建术后癫痫发作的危险因素分析 [J]. 中华神经外科杂志, 2019, 35(7): 664-668.
|